- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
December 29th, 2006
An Indian-American scientist has won a USD 4.1 million award given by the US Department of Defence (DoD) for breast cancer research.
His recent work brought together cancer biology, pharmacology and engineering to create an anti-cancer drug delivery device dubbed the nanocell. This technology has the potential to eliminate the systemic toxicity caused by chemotherapy by directing drugs to act only where they are needed. The concept is now being commercialised by Tempo Pharmaceuticals, which is a MIT start-up.
|Related News Press|
Nanoparticles simplify DNA identification and quantification November 27th, 2015
Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015
Electric fields remove nanoparticles from blood with ease November 24th, 2015
Researchers find new phase of carbon, make diamond at room temperature November 30th, 2015
Omni Nano and Time Warner Cable Partner to Provide Nanotechnology Education to the Boys & Girls Clubs of Los Angeles: A $10,000 Donation to Benefit Youth of Los Angeles County's Boys & Girls Clubs August 4th, 2015
Kalam: versatility personified August 1st, 2015
Coming to a monitor near you: A defect-free, molecule-thick film November 29th, 2015